Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1telehealthobesity

Allure Examines How GLP-1s Moved Beyond the Doctor's Office

The feature traces the spread of weight-loss drugs into telehealth, med spas and consumer culture.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 12:05 ETSource: Allure

The wire

  1. 01Allure published a feature on GLP-1 use outside traditional clinical settings.
  2. 02Nonclinical distribution channels raise oversight and safety questions.
  3. 03Article does not report new regulatory or enforcement developments.

From the source

How GLP-1s Left the Doctor's Office

Read at news.google.com